# FODZYME

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/fodzyme

- Industry: Food
- Headquarters: Cambridge, US
- Website: www.kiwibiosciences.com/
- Total disclosed funding: $1.5M
- Latest round: Seed (Oct 14, 2021)
- Investors on record: 4

## About

Founded in 2020 and based in MA, US, Kiwi Health, Inc. doing business as Fodzyme provides enzymes solution for irritable bowel syndrome (IBS). In October 2021, the firm raised USD 1.5 million in Seed funding from investors Y Combinator, North-South Ventures, Acacia Venture Capital, Surf Club Ventures, and Savage Seed Fund. Individual investors also participated in the round.

The company offers Fodzyme which is an enzyme-based formula to relieve gut issues. It breaks down digestive triggers in garlic, onion, wheat, banana, and many other food products so that it can help in reducing gut disorders. The firm product range includes a home kit, an on-the-go kit, and an anywhere bundle.

The firm generates revenue by selling the Home Kit and On-The-Go-Kit at USD 65, and the Anywhere bundle at USD 119.

## Funding rounds

- Seed, Oct 14, 2021, $1.5M — Y Combinator, North South Ventures, Acacia Venture Capital Partners, Surf Club Ventures

## Investors

- Y Combinator (https://capitalatlas.ai/funds/y-combinator) — Seed
- North South Ventures (https://capitalatlas.ai/funds/north-south-ventures) — Seed
- Acacia Venture Capital Partners (https://capitalatlas.ai/funds/acacia-venture-capital-partners) — Seed
- Surf Club Ventures (https://capitalatlas.ai/funds/surf-club-ventures) — Seed